Hipertensión arterial severa con nefroangioesclerosis: tratamiento y evolución a largo plazo

Marín, 2002, Arterial hypertension and renal vascular disease: nephroangiosclerosis, Nefrologia, 22, 36 Gorostidi, 2004, Mild renal insufficiency and microalbuminuria as emerging cardiovascular risk factors, Nefrologia, 24, 47 Hermann, 2006, Nitric oxide in hypertension, J Clin Hypertens (Greenwich), 8, 17, 10.1111/j.1524-6175.2006.06032.x Chobanian, 2003, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report, Jama, 21, 2560, 10.1001/jama.289.19.2560 Nakao, 2004, Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy, Am J Nephrol, 24, 543, 10.1159/000081953 Nakao, 2003, Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial, Lancet, 361, 117, 10.1016/S0140-6736(03)12229-5 Anguita Sánchez, 2004, Clinical outcome and reversibility of systolic dysfunction in patients with dilated cardiomyopathy due to hypertension and chronic heart failure, Rev Esp Cardiol, 57, 834, 10.1016/S1885-5857(06)60648-8 Franco, 2004, Hypertensive therapy: Part II, Circulation, 109, 3081, 10.1161/01.CIR.0000132615.44103.B1 Franco, 2004, Hypertensive therapy: Part I, Circulation, 109, 2953, 10.1161/01.CIR.0000132614.41493.B5